Envoy Medical (NASDAQ:COCH) Stock Price Down 1% – What’s Next?

Shares of Envoy Medical, Inc. (NASDAQ:COCH) fell 1% during mid-day trading on Monday . The company traded as low as $1.38 and last traded at $1.42. 27,689 shares changed hands during mid-day trading, a decline of 70% from the average session volume of 92,724 shares. The stock had previously closed at $1.43.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets upped their price target on shares of Envoy Medical from $8.75 to $9.00 and gave the stock a “buy” rating in a research report on Friday, December 6th.

Envoy Medical Stock Down 1.4 %

The company has a 50 day moving average price of $1.47 and a 200-day moving average price of $2.05.

Institutional Investors Weigh In On Envoy Medical

Several hedge funds have recently made changes to their positions in the company. Citadel Advisors LLC bought a new position in Envoy Medical during the fourth quarter valued at approximately $42,000. CIBC Private Wealth Group LLC bought a new stake in Envoy Medical in the fourth quarter valued at about $65,000. Lake Street Advisors Group LLC acquired a new stake in Envoy Medical during the fourth quarter valued at approximately $65,000. Finally, DSG Capital Advisors LLC acquired a new position in Envoy Medical during the fourth quarter worth $234,000. Hedge funds and other institutional investors own 8.59% of the company’s stock.

About Envoy Medical

Envoy Medical, Inc, a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc in September 2023.